Unlocking the power of exosomes for crossing biological barriers in drug delivery

RO Elliott, M He - Pharmaceutics, 2021 - mdpi.com
Since the 2013 Nobel Prize was awarded for the discovery of vesicle trafficking, a subgroup
of nanovesicles called exosomes has been driving the research field to a new regime for …

Metal drugs and the anticancer immune response

B Englinger, C Pirker, P Heffeter, A Terenzi… - Chemical …, 2018 - ACS Publications
The immune system deploys a multitude of innate and adaptive mechanisms not only to
ward off pathogens but also to prevent malignant transformation (“immune surveillance”) …

Mechanisms of cisplatin-induced ototoxicity and otoprotection

S Sheth, D Mukherjea, LP Rybak… - Frontiers in cellular …, 2017 - frontiersin.org
Evidence of significant hearing loss during the early days of use of cisplatin as a
chemotherapeutic agent in cancer patients has stimulated research into the causes and …

[HTML][HTML] Cisplatin-induced ototoxicity: From signaling network to therapeutic targets

X Wang, Y Zhou, D Wang, Y Wang, Z Zhou… - Biomedicine & …, 2023 - Elsevier
Administration of cisplatin, a common chemotherapeutic drug, has an inevitable side effect
of sensorineural hearing loss. The main etiologies are stria vascularis injury, spiral ganglion …

Oxidative stress and inflammation caused by cisplatin ototoxicity

V Ramkumar, D Mukherjea, A Dhukhwa, LP Rybak - Antioxidants, 2021 - mdpi.com
Hearing loss is a significant health problem that can result from a variety of exogenous
insults that generate oxidative stress and inflammation. This can produce cellular damage …

NADPH oxidase 4 promotes cisplatin-induced acute kidney injury via ROS-mediated programmed cell death and inflammation

XM Meng, GL Ren, L Gao, Q Yang, HD Li… - Laboratory …, 2018 - nature.com
The goal of this study was to elucidate the functional role of Nox4 during acute kidney injury
(AKI). NADPH oxidases are a major source of reactive oxygen species (ROS) in the kidney …

Cisplatin-induced ototoxicity: Updates on molecular mechanisms and otoprotective strategies

Q Tang, X Wang, H Jin, Y Mi, L Liu, M Dong… - European Journal of …, 2021 - Elsevier
Cisplatin is a highly effective antitumor drug generally used in the treatment of solid
malignant tumors. However, cisplatin causes severe side effects such as bone marrow …

Current strategies to combat cisplatin-induced ototoxicity

D Yu, J Gu, Y Chen, W Kang, X Wang… - Frontiers in …, 2020 - frontiersin.org
Cisplatin is widely used for the treatment of a number of solid malignant tumors. However,
ototoxicity induced by cisplatin is an obstacle to effective treatment of tumors. The basis for …

Mechanisms of cisplatin-induced ototoxicity and prevention

LP Rybak, D Mukherjea, V Ramkumar - Seminars in hearing, 2019 - thieme-connect.com
Cisplatin is a highly effective antineoplastic agent used to treat solid tumors. Unfortunately,
the administration of this drug leads to significant side effects, including ototoxicity …

Pro-inflammatory signalling PRRopels cisplatin-induced toxicity

IK Domingo, A Latif, AP Bhavsar - International journal of molecular …, 2022 - mdpi.com
Cisplatin is a platinum-based chemotherapeutic that has long since been effective against a
variety of solid-cancers, substantially improving the five-year survival rates for cancer …